| The projected economic and health burden of uncontrolled asthma in the United States M Yaghoubi, A Adibi, A Safari, JM FitzGerald, M Sadatsafavi American journal of respiratory and critical care medicine 200 (9), 1102-1112, 2019 | 246 | 2019 |
| Validation and Utility Testing of Clinical Prediction Models: Time to Change the Approach A Adibi, M Sadatsafavi, JPA Ioannidis JAMA, 2020 | 96 | 2020 |
| The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study A Adibi, DD Sin, A Safari, KM Johnson, SD Aaron, JM FitzGerald, ... The Lancet Respiratory Medicine 8 (10), 1013-1021, 2020 | 86 | 2020 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 58 | 2023 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 33 | 2024 |
| Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling S Harvard, E Winsberg, J Symons, A Adibi Social Science & Medicine 286, 114323, 2021 | 24 | 2021 |
| Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models M Sadatsafavi, A Adibi, M Puhan, A Gershon, SD Aaron, DD Sin European Respiratory Journal 58 (5), 2021 | 23 | 2021 |
| Combined endovascular coiling and intra-aneurysmal allogeneic mesenchymal stromal cell therapy for intracranial aneurysms in a rabbit model: a proof-of-concept study A Adibi, M Eesa, JH Wong, A Sen, AP Mitha Journal of neurointerventional surgery 9 (7), 707-712, 2017 | 23 | 2017 |
| Cell Therapy for Intracranial Aneurysms: A Review A Adibi, A Sen, AP Mitha World neurosurgery 86, 390-398, 2016 | 22 | 2016 |
| An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population W Chen, DD Sin, JM FitzGerald, A Safari, A Adibi, M Sadatsafavi Chest 157 (3), 547-557, 2020 | 20 | 2020 |
| Looking at the COPD spectrum through “PRISm” A Adibi, M Sadatsafavi European Respiratory Journal 55 (1), 2020 | 19 | 2020 |
| Development and validation of the Evaluation Platform In COPD (EPIC): a population-based outcomes model of COPD for Canada M Sadatsafavi, S Ghanbarian, A Adibi, K Johnson, JM FitzGerald, ... Medical Decision Making 39 (2), 152-167, 2019 | 16 | 2019 |
| Cost effectiveness of case detection strategies for the early detection of COPD KM Johnson, M Sadatsafavi, A Adibi, L Lynd, M Harrison, H Tavakoli, ... Applied Health Economics and Health Policy 19 (2), 203-215, 2021 | 12 | 2021 |
| Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States M Yaghoubi, A Adibi, Z Zafari, JM FitzGerald, SD Aaron, KM Johnson, ... Journal of Allergy and Clinical Immunology 145 (5), 1367-1377. e4, 2020 | 12 | 2020 |
| ACCEPT 2· 0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT) A Safari, A Adibi, DD Sin, TY Lee, JK Ho, M Sadatsafavi EClinicalMedicine 51, 2022 | 9 | 2022 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 8 | 2024 |
| Generalizability of Risk Stratification Algorithms for Exacerbations in COPD JK Ho, A Safari, A Adibi, DD Sin, K Johnson, M Sadatsafavi Chest, 2022 | 7 | 2022 |
| Programmable Interface for Statistical & Simulation Models (PRISM): Towards Greater Accessibility of Clinical and Healthcare Decision Models A Adibi, S Harvard, M Sadatsafavi arXiv preprint arXiv:2202.08358, 2022 | 7 | 2022 |
| Lowering the P Value Threshold A Adibi, D Sin, M Sadatsafavi JAMA 321 (15), 1532-1533, 2019 | 6 | 2019 |
| Innovation in unruptured intracranial aneurysm coiling: At which price or efficacy are new technologies cost-effective? D Ben-Israel, BL Belanger, A Adibi, M Eesa, AP Mitha, E Spackman Plos one 16 (8), e0255870, 2021 | 5 | 2021 |
Mohsen SadatsafaviAssociate Professor, the University of British Columbia在 mail.ubc.ca 的电子邮件经过验证
